Reuters: Health
Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday.
Takeda says coronavirus treatment trial using recovered patients' blood could start in July
Takeda says coronavirus treatment trial using recovered patients' blood could start in July
Reuters: Health
Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday.
Reuters: Health
Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients' blood, company executives said on Wednesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment